Roundtable Discussion: Overcoming Cell Sourcing Challenges to Advance Translational & Preclinical Dermatology Research
Time: 11:30 am
day: Day One AM
Details:
- Evaluating primary human keratinocytes and fibroblasts versus immortalized or stem cell‑derived lines for disease modeling
- Addressing variability and reproducibility across donor-derived cells and commercial suppliers
- Optimizing sourcing strategies for rare or inflamed patient-derived skin samples in inflammatory and autoimmune indications
- Integrating 3D skin models and organoids with well-characterized cell populations to improve translational relevance
